ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,199 | +26.0% | 2,317 | +41.5% | 0.00% | 0.0% |
Q2 2023 | $46,978 | +19.6% | 1,638 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $39,263 | +27.0% | 1,638 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $30,925 | +28.9% | 1,638 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $24,000 | -4.0% | 1,638 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $25,000 | -43.2% | 1,638 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $44,000 | -27.9% | 1,638 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $61,000 | -21.8% | 1,638 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $78,000 | +41.8% | 1,638 | 0.0% | 0.00% | +50.0% |
Q2 2021 | $55,000 | -19.1% | 1,638 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $68,000 | -15.0% | 1,638 | -11.2% | 0.00% | -25.0% |
Q4 2020 | $80,000 | +35.6% | 1,844 | +35.2% | 0.00% | +33.3% |
Q3 2020 | $59,000 | +9.3% | 1,364 | +18.4% | 0.00% | 0.0% |
Q2 2020 | $54,000 | – | 1,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |